Search
Aytu Biopharma Inc
AYTUAdd to Watchlist
1.830USD
+0.020+1.10%
Close 11-06 16:00（ET）
19.89MMarket Cap
LossP/E TTM
Today
+1.10%
5 Days
-5.18%
1 Month
-10.73%
6 Months
-28.52%
Year to Date
-29.62%
1 Year
-14.49%
Key Figures
1.820Open
1.950High
667.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
1.810Prev. Close
1.750Low
1.17KTurnover
LossP/E Static
0.54P/B
0.00%Div Yield TTM
-28.93%ROA
3.06552wk High
0.07Volume Ratio
-13.56MNet Profit
10.87MShares
-4.6080EPS TTM
0.24Beta
-97.42%ROE
1.75052wk Low
9.39%Amplitude
59.62%Gross Margin
19.89MMarket Cap
3.12Reward/Risk
2.79%Risk Rate
Aytu Biopharma Inc's Score
0.06vs previous score
Forecast8.00
Financial Health7.23
Technical3.97
Valuation Dimensions8.74
Institutional Confidence3.00
Risk Assessment4.02
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Aytu Biopharma Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Aytu Biopharma Inc Latest Earnings Call Transcripts
Aytu BioPharma (AYTU) Fiscal Q4 2026 Earnings Call: EXXUA Growth and FY2027 Outlook
Aytu BioPharma fiscal Q4 2026 revenue rose 6% to $16.1 million as EXXUA sales reached $3.9 million. Management outlined fiscal 2027 spending and margin targets.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q4
Earnings / Forecast
-0.00/-0.33
Revenue / Forecast
16.11M/12.28M
Aytu Biopharma Inc Profile
SectorPharmaceuticals
Ticker SymbolAYTU
Number of employees82
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Nantahala Capital Management, LLC | 10.13% |
| Stonepine Capital Management, LLC | 7.58% |
| AWM Investment Company, Inc. | 5.77% |
| Lytton (Laurence W) | 4.99% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 16.18% |
| Hedge Fund | 16.10% |
| Individual Investor | 8.98% |
| Investment Advisor | 3.85% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Aytu Biopharma Inc (AYTU)?
The current price of Aytu Biopharma Inc (AYTU) is 1.83.
What is the symbol of Aytu Biopharma Inc?
The ticker symbol of Aytu Biopharma Inc is AYTU.
What is the 52-week high of Aytu Biopharma Inc?
The 52-week high of Aytu Biopharma Inc is 3.06.
What is the 52-week low of Aytu Biopharma Inc?
The 52-week low of Aytu Biopharma Inc is 1.75.
What is the market capitalization of Aytu Biopharma Inc?
The market capitalization of Aytu Biopharma Inc is 19.89M.
Is Aytu Biopharma Inc (AYTU) currently rated as Buy, Hold, or Sell?
According to analysts, Aytu Biopharma Inc (AYTU) has an overall rating of Buy, with a price target of 9.67.
What is the Earnings Per Share (EPS TTM) of Aytu Biopharma Inc (AYTU)?
The Earnings Per Share (EPS TTM) of Aytu Biopharma Inc (AYTU) is -4.61.